Abiopharma

Clinical trial NCT05891171 updates: 1. completion date: 2026-03-01 → 2027-09-01 2. primary completion date: 2026-03-01 → 2027-09-01

Clinical trial NCT06024772: start date: 2026-03-15 → 2026-07-01.

Clinical trial NCT07309445 updates: 1. start date: 2026-04-30 → 2026-06-30 2. completion date: 2029-10-31 → 2029-10-09

Clinical trial NCT05083182: completion date: 2026-12-05 → 2026-06-24.

Clinical trial NCT06544616: completion date: 2026-12-22 → 2027-01-05.

Clinical trial NCT05538130 updates: 1. completion date: 2029-02-07 → 2029-06-18 2. primary completion date: 2027-08-09 → 2027-08-02

Clinical trial NCT04097158 updates: 1. completion date: 2026-04-01 → 2027-04-01 2. primary completion date: 2026-04-01 → 2027-04-01

Clinical trial NCT04098666: primary completion date: 2026-05-12 → 2026-04-23.

Clinical trial NCT06095089 updates: 1. enrollment: 250 → 355 participants 2. allocation: NA → NON_RANDOMIZED

Clinical trial NCT06481319 updates: 1. status: RECRUITING → ACTIVE_NOT_RECRUITING 2. completion date: 2026-05-01 → 2026-07-01 3. primary completion date: 2026-05-01 → 2026-07-01 4. enrollment: 40 → 28 participants 5. enrollment type: ESTIMATED → ACTUAL